Susan C. Weil - Concepedia

Author

Susan C. Weil

Also Known As

Armstrong, Deborah K., S C Weil, S Weil, S. C. Weil, S. WEIL, S. Weil, S.C Weil, S.C. Weil, SUSAN C. WEIL, Susan C. Weil

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Morphotek (United States)Northwestern University Thomas Jefferson University Center for Cancer Research University of California, Los Angeles

About

Susan C. Weil is an author at Morphotek (United States) specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	838
2	Natural Sciences	5	5	158
3	Biochemistry	4	4	135
4	Engineering	1	1	71
5	Allergy	1	1	37

Susan C. Weil

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers Raffit Hassan, Steven J. Cohen, Martin D. Phillips, Clinical Cancer Research	2010	199
Farletuzumab, a Humanized Monoclonal Antibody against Folate Receptor α, in Epithelial Ovarian Cancer: a Phase I Study Jason Konner, Katherine M. Bell‐McGuinn, Paul Sabbatini, Clinical Cancer Research	2010	157
Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer Deborah K. Armstrong, Allen J. White, Susan C. Weil, Gynecologic Oncology MedicineFolate Receptor AlphaPathologyGynecologyPlatinum-sensitive Ovarian Cancer	2013	149
A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First Platinum-Sensitive Relapse Ignace Vergote, Deborah K. Armstrong, Giovanni Scambia, Journal of Clinical Oncology	2016	149
Changes in RNA metabolism and accumulation of presumptive messenger RNA during transition from the growing to the quiescent state of cultured mouse fibroblasts P S Rudland, Susan C. Weil, A. R. Hunter Journal of Molecular Biology Rna MetabolismDevelopmental BiologyRna BiologyCultured Mouse FibroblastsPresumptive Messenger Rna	1975	108
Prostate cancer treatment with Irreversible Electroporation (IRE): Safety, efficacy and clinical experience in 471 treatments Enric Guenther, Nina Klein, S Zapf, PLoS ONE	2019	98
Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy Raffit Hassan, Charles Schweizer, Kun F. Lu, Lung Cancer Cancer TherapyMedicineImmunologyAnti-cancer AgentMesothelin–ca-125 Interaction	2009	74
Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk Xiaowei Chen, Joellen Weaver, Betsy Bove, Human Molecular Genetics Breast OncologyEngineeringGeneticsBrca2 ExpressionCancer Biology	2008	71
cDNA cloning of human myeloperoxidase: decrease in myeloperoxidase mRNA upon induction of HL-60 cells. Susan C. Weil, Gary L. Rosner, Martha S. Reid, Proceedings of the National Academy of Sciences Mixed-phenotype Acute LeukemiaImmunologyMyeloperoxidase MrnaMolecular BiologyPathology	1987	66
A First-in-Human Phase I Study of MORAb-004, a Monoclonal Antibody to Endosialin in Patients with Advanced Solid Tumors Luis A. Díaz, Christina Coughlin, Susan C. Weil, Clinical Cancer Research	2014	55

Page 1